id | C00005372 |
---|---|
Name | Hyperin / Hyperoside / Quercetin 3-O-galactoside / Quercetin 3-O-beta-D-galactoside / Quercetin 3-beta-galactopyranoside / Quercetin 3-O-beta-D-galactopyranoside |
CAS RN | 482-36-0 |
Standard InChI | InChI=1S/C21H20O12/c22-6-13-15(27)17(29)18(30)21(32-13)33-20-16(28)14-11(26)4-8(23)5-12(14)31-19(20)7-1-2-9(24)10(25)3-7/h1-5,13,15,17-18,21-27,29-30H,6H2/t13-,15+,17?,18?,21+/m1/s1 |
Standard InChI (Main Layer) | InChI=1S/C21H20O12/c22-6-13-15(27)17(29)18(30)21(32-13)33-20-16(28)14-11(26)4-8(23)5-12(14)31-19(20)7-1-2-9(24)10(25)3-7/h1-5,13,15,17-18,21-27,29-30H,6H2 |
Phytochemical cluster | No. 15 |
---|---|
KCF-S cluster | No. 2 |
By standard InChI | |
---|---|
By standard InChI Main Layer | CHEMBL33027 CHEMBL309323 CHEMBL250450 CHEMBL251254 CHEMBL457304 CHEMBL1098724 CHEMBL2337335 CHEMBL2337336 |
By LinkDB | C10073 |
---|
By CAS RN | C021304 |
---|
class name | count |
---|---|
rosids | 37 |
asterids | 21 |
eudicotyledons | 6 |
Liliopsida | 3 |
Spermatophyta | 2 |
Magnoliophyta | 1 |
Euphyllophyta | 1 |
family name | count |
---|---|
Fabaceae | 13 |
Hypericaceae | 9 |
Asteraceae | 8 |
Ericaceae | 3 |
Rubiaceae | 3 |
Polygonaceae | 2 |
Myrtaceae | 2 |
Rosaceae | 2 |
Urticaceae | 2 |
Saxifragaceae | 2 |
accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|---|
Q9NPH5 | NADPH oxidase 4 | Enzyme | CHEMBL1098724 |
CHEMBL1249157
(1)
CHEMBL1249158
(1)
CHEMBL1249160 (1) |
0 / 0 |
Q16637 | Survival motor neuron protein | Unclassified protein | CHEMBL33027 |
CHEMBL1613842
(1)
|
4 / 2 |
Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | CHEMBL251254 |
CHEMBL1738312
(1)
|
0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | CHEMBL250450 |
CHEMBL1008559
(1)
CHEMBL1693776
(1)
|
0 / 3 |
P06746 | DNA polymerase beta | Enzyme | CHEMBL250450 CHEMBL251254 |
CHEMBL1614079
(2)
|
0 / 0 |
P04062 | Glucosylceramidase | Enzyme | CHEMBL251254 |
CHEMBL1613818
(1)
|
6 / 4 |
P10253 | Lysosomal alpha-glucosidase | Hydrolase | CHEMBL33027 CHEMBL250450 CHEMBL251254 |
CHEMBL1614175
(1)
CHEMBL1614076
(3)
|
1 / 1 |
P02545 | Prelamin-A/C | Unclassified protein | CHEMBL251254 |
CHEMBL1614544
(1)
|
11 / 10 |
P47989 | Xanthine dehydrogenase/oxidase | Oxidoreductase | CHEMBL250450 |
CHEMBL1014040
(2)
|
1 / 1 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | CHEMBL1098724 |
CHEMBL1120976
(1)
|
0 / 0 |
P07237 | Protein disulfide-isomerase | Enzyme | CHEMBL33027 |
CHEMBL1964080
(1)
CHEMBL2114805
(1)
|
0 / 0 |
Q9NR56 | Muscleblind-like protein 1 | Unclassified protein | CHEMBL33027 CHEMBL250450 CHEMBL251254 |
CHEMBL1614166
(3)
|
1 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | CHEMBL250450 |
CHEMBL926465
(1)
|
0 / 0 |
P36888 | Receptor-type tyrosine-protein kinase FLT3 | Pdgfr | CHEMBL250450 CHEMBL2337335 CHEMBL2337336 |
CHEMBL2342404
(3)
|
1 / 1 |
P39748 | Flap endonuclease 1 | Enzyme | CHEMBL33027 |
CHEMBL1794486
(1)
|
0 / 0 |
O75496 | Geminin | Unclassified protein | CHEMBL33027 |
CHEMBL2114780
(1)
|
0 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | CHEMBL250450 |
CHEMBL926467
(1)
|
0 / 0 |
P15121 | Aldose reductase | Enzyme | CHEMBL250450 |
CHEMBL1942674
(2)
|
0 / 0 |
Q9Y253 | DNA polymerase eta | Enzyme | CHEMBL33027 |
CHEMBL1794569
(1)
|
1 / 1 |
P09923 | Intestinal-type alkaline phosphatase | Enzyme | CHEMBL250450 |
CHEMBL1738679
(1)
CHEMBL1738192
(1)
|
0 / 0 |
P05186 | Alkaline phosphatase, tissue-nonspecific isozyme | Enzyme | CHEMBL250450 |
CHEMBL1738602
(1)
|
3 / 1 |
P14679 | Tyrosinase | Oxidoreductase | CHEMBL250450 |
CHEMBL814345
(1)
|
4 / 2 |
P06280 | Alpha-galactosidase A | Enzyme | CHEMBL251254 |
CHEMBL1614217
(1)
|
1 / 1 |
P28482 | Mitogen-activated protein kinase 1 | Erk | CHEMBL251254 |
CHEMBL1614521
(1)
|
0 / 0 |
P10696 | Alkaline phosphatase, placental-like | Enzyme | CHEMBL250450 |
CHEMBL1738040
(1)
|
0 / 1 |
Q9UNQ0 | ATP-binding cassette sub-family G member 2 | ATP binding cassette | CHEMBL250450 |
CHEMBL1687393
(1)
CHEMBL1687394
(1)
|
2 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | CHEMBL250450 |
CHEMBL926466
(1)
|
0 / 0 |
Q9UNA4 | DNA polymerase iota | Enzyme | CHEMBL33027 |
CHEMBL1794483
(1)
|
0 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | CHEMBL33027 CHEMBL250450 CHEMBL251254 |
CHEMBL1614211
(3)
|
0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | CHEMBL250450 CHEMBL251254 |
CHEMBL1614421
(2)
|
4 / 3 |
P08908 | 5-hydroxytryptamine receptor 1A | Serotonin receptor | CHEMBL250450 |
CHEMBL993916
(1)
|
1 / 0 |
P34949 | Mannose-6-phosphate isomerase | Enzyme | CHEMBL33027 |
CHEMBL1614255
(1)
|
1 / 1 |
Q9UBT6 | DNA polymerase kappa | Enzyme | CHEMBL33027 |
CHEMBL1794536
(1)
|
0 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | CHEMBL33027 CHEMBL250450 CHEMBL251254 |
CHEMBL1613914
(3)
|
0 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | CHEMBL250450 CHEMBL251254 |
CHEMBL1738442
(2)
|
0 / 0 |
Q13951 | Core-binding factor subunit beta | Unclassified protein | CHEMBL33027 |
CHEMBL1613933
(1)
|
0 / 1 |
Q01196 | Runt-related transcription factor 1 | Unclassified protein | CHEMBL33027 |
CHEMBL1613933
(1)
|
1 / 6 |
O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | CHEMBL33027 |
CHEMBL2114738
(1)
|
0 / 0 |
compound | gene | gene name | gene description | interaction | interaction type | form |
reference
pmid |
---|---|---|---|---|---|---|---|
C021304 | 581 |
BAX
BCL2L4 |
BCL2-associated X protein | hyperoside inhibits the reaction [tert-Butylhydroperoxide affects the localization of BAX protein] |
affects localization
/ decreases reaction |
protein |
18552516
|
C021304 | 54205 |
CYCS
CYC HCS THC4 |
cytochrome c, somatic | hyperoside inhibits the reaction [tert-Butylhydroperoxide affects the localization of CYCS protein] |
affects localization
/ decreases reaction |
protein |
18552516
|
C021304 | 2099 |
ESR1
ER ESR ESRA ESTRR Era NR3A1 |
estrogen receptor 1 | hyperoside inhibits the reaction [Estradiol results in increased activity of ESR1 protein] |
decreases reaction
/ increases activity |
protein |
22613215
|
C021304 | 23411 |
SIRT1
SIR2L1 |
sirtuin 1 | hyperoside inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of SIRT1 protein] |
decreases expression
/ decreases reaction |
protein |
18552516
|
OMIM | preferred title | UniProt |
---|---|---|
#103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
#203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
#606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
#614490 | Blood group, junior system; jr |
Q9UNQ0
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#602579 | Congenital disorder of glycosylation, type ib; cdg1b |
P34949
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#301500 | Fabry disease |
P06280
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#608013 | Gaucher disease, perinatal lethal |
P04062
|
#230800 | Gaucher disease, type i |
P04062
|
#230900 | Gaucher disease, type ii |
P04062
|
#231000 | Gaucher disease, type iii |
P04062
|
#231005 | Gaucher disease, type iiic |
P04062
|
#232300 | Glycogen storage disease ii |
P10253
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#146300 | Hypophosphatasia, adult |
P05186
|
#241510 | Hypophosphatasia, childhood |
P05186
|
#241500 | Hypophosphatasia, infantile |
P05186
|
#601626 | Leukemia, acute myeloid; aml |
P36888
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#160900 | Myotonic dystrophy 1; dm1 |
Q9NR56
|
#168600 | Parkinson disease, late-onset; pd |
P04062
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#614674 | Periodic fever, menstrual cycle-dependent |
P08908
|
#172700 | Pick disease of brain |
P10636
|
#601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#138900 | Uric acid concentration, serum, quantitative trait locus 1; uaqtl1 |
Q9UNQ0
|
#278300 | Xanthinuria, type i |
P47989
|
#278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
KEGG | disease name | UniProt |
---|---|---|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00066 | Lewy body dementia (LBD) |
P04062
(related)
|
H00126 | Gaucher disease |
P04062
(related)
|
H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
H00213 | Hypophosphatasia |
P05186
(related)
|
H00125 | Fabry disease |
P06280
(related)
|
H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00023 | Testicular cancer |
P10696
(marker)
|
H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
H00038 | Malignant melanoma |
P14679
(marker)
|
H00118 | Congenital disorders of glycosylation (CDG) type I |
P34949
(related)
|
H00017 | Esophageal cancer |
P35354
(related)
|
H00025 | Penile cancer |
P35354
(related)
|
H00046 | Cholangiocarcinoma |
P35354
(related)
|
H00003 | Acute myeloid leukemia (AML) |
P36888
(related)
Q01196 (related) Q01196 (marker) Q13951 (marker) |
H00192 | Xanthinuria |
P47989
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) |
H00004 | Chronic myeloid leukemia (CML) |
Q01196
(related)
|
H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
Q16637 (related) |
H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|